Back to Agenda
Plenary Session: Quantitative Sciences for Pharmaceutical Development Decision Making
Session Chair(s)
Qin Huang, PhD
Deputy Director, Office of Biostatistics
Center For Drug Evaluation, CFDA, China
William Wang, PhD
President
Merck & Co, Inc, United States
Speaker(s)
Ling Su, PhD
Shenyang Pharmaceutical University, Yeehong Business School, China
Research Fellow
The Role of Quantitative Sciences in US Regulatory Decision-Making
Lisa LaVange, PhD
University of North Carolina at Chapel Hill, United States
Professor Emerita
Statistical Review for Clinical Trials: Reality and Prospective in China
Qin Huang, PhD
Center For Drug Evaluation, CFDA, China
Deputy Director, Office of Biostatistics
Roles of Academia Statisticians for Drug Review in China
Feng Chen, PhD
School of Public Health, Nanjing Medical University, China
Professor, Dean
Have an account?